.

Wilate

Human Von Willebrand factor and Human coagulation factor VIII

 

  • Composition
    Each vial with lyophilized powder contains the following active pharmaceutical ingredients:
    Wilate 500: 500 IU of Human Von Willebrand factor and 500 IU of Human coagulation factor VIII.

  • Indications
    - Von Willebrand disease
    Wilate is used to treat and prevent bleeding in patients with Von Willebrand disease (VWD), which is a group of related diseases. All types of VWD are inherited diseases where bleeding may last longer than expected. This may be due to a lack of VWF in the blood or that the VWF does not work as it should.

    - Haemophilia A
    Wilate is used to treat and prevent bleeding in haemophilia A patients.
    In that disease bleeding may last longer than expected. It is due to an inborn lack of FVIII in the blood.
     

  • Contraindications
    Hypersensitivity to any ingredient of this product.

  • Presentation
    Wilate 500: box containing one vial with lyophilized powder + one vial with 10 mL of solvent + the injection kit.